According to research that will be presented at ASCO’s 2014 Quality Care Symposium, 64% of parents with advanced cancer chose life-extending treatments, indicating that having children is an important factor in treatment decision-making.
For early-stage breast cancer, doctors generally recommend surgery to remove the tumor. But choosing between a lumpectomy and mastectomy can sometimes be difficult. Deanna Attai, MD, FACS, a breast cancer surgeon, provides information and advice to help women talk with their doctors about this decision.
New Insight on the Factors Affecting Local and Regional Recurrence from the 2014 Breast Cancer Symposium
Learn more about the results of a large study that has identified two factors that may help predict the chance that breast cancer will come back in the breast or nearby areas better than the cancer’s stage.
Get highlights of two studies that provide insight into why some women with early-stage breast cancer choose to have a double mastectomy and the risk of complications they may experience after this surgery.
Colon cancer survivor David Nethero describes how he used meditation and positive mental imagery to cope with some of the physical side effects of chemotherapy and be present in the moment.
There are so many things to consider before a trip, but what about if you are traveling to receive cancer treatment? Here is some practical advice to help ease your mind and make the transition a bit easier.
Prostate cancer patient advocate Alvin Chin describes how his experiences in Chicago satisfied his “sweet tooth” for relevant and important cancer information.
Research Highlights on Immunotherapy for Melanoma and Cervical Cancer From the 2014 ASCO Annual Meeting
Activating and amplifying the body’s immune response to cancer is an exciting area of research. See how it is being used to better treat advanced or high-risk melanoma and cervical cancer in these four studies presented in Chicago today.
Get highlights of four pivotal studies that reveal new ways to optimize commonly used chemotherapy, hormone therapy, and newer targeted drugs, and answer critical questions about the effectiveness of two common treatment regimens for advanced colorectal cancer.
Learn more about four studies that show the potential of new targeted therapies for advanced ovarian, lung, and thyroid cancers and chronic lymphocytic leukemia.